Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States.
Calderon MA, Casale TB, Nelson HS, Bacharier LB, Bansal P, Bernstein DI, Blaiss M, Corren J, DuBuske L, Fatteh S, Gagnon R, Greiwe J, Hoover H, Kolinsky NC, Namazy JA, Phipatanakul W, Plunkett G, Shaker M, Waserman S, Winders T, Rance K, Nolte H. Calderon MA, et al. Among authors: nolte h. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1100-1115. doi: 10.1016/j.jaip.2022.10.033. Epub 2022 Nov 4. J Allergy Clin Immunol Pract. 2023. PMID: 36343885 Free article. Review.
House dust mite sublingual immunotherapy tablet safety in adolescents with allergic rhinoconjunctivitis: Worldwide clinical trial results.
Horn A, Bernstein DI, Okubo K, Dalgaard T, Hels O, Sørensen HF, Henriksen M, Azuma R, Mikler J, Nolte H. Horn A, et al. Among authors: nolte h. Ann Allergy Asthma Immunol. 2023 Jun;130(6):797-804.e2. doi: 10.1016/j.anai.2023.03.006. Epub 2023 Mar 15. Ann Allergy Asthma Immunol. 2023. PMID: 36924936 Free article. Clinical Trial.
Anaphylaxis in Clinical Trials of Sublingual Immunotherapy Tablets.
Nolte H, Calderon MA, Bernstein DI, Roberts G, Azuma R, Juhl RG, Hulstrøm V. Nolte H, et al. J Allergy Clin Immunol Pract. 2024 Jan;12(1):85-95.e4. doi: 10.1016/j.jaip.2023.11.011. Epub 2023 Nov 14. J Allergy Clin Immunol Pract. 2024. PMID: 37972922 Free article.
The Art of Dosing for Subcutaneous Immunotherapy in North America.
Nelson HS, Sowers T, Plunkett G, Nolte H, Rance K. Nelson HS, et al. Among authors: nolte h. J Allergy Clin Immunol Pract. 2024 Jan;12(1):13-22. doi: 10.1016/j.jaip.2023.06.036. Epub 2023 Jun 28. J Allergy Clin Immunol Pract. 2024. PMID: 37385447 Review.
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.
Creticos PS, Gunaydin FE, Nolte H, Damask C, Durham SR. Creticos PS, et al. Among authors: nolte h. J Allergy Clin Immunol Pract. 2024 Apr 27:S2213-2198(24)00419-7. doi: 10.1016/j.jaip.2024.04.034. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 38685477 Review.
388 results